 mitoxantron high-dos etoposid patient relaps refractori acut leukemia patient relaps refractori acut myelogen leukemia aml salvag chemotherapi mitoxantron IV hour day etoposid day daili infus daili dose seven patient mitoxantron day day median durat initi complet remiss CR month patient initi CR month forty-six percent patient second subsequ salvag attempt patient CR CR cours therapi patient patient diseas resist treatment patient first salvag attempt incid rate CR second subsequ salvag attempt CR rate patient favor transloc diploid karyotyp patient median surviv time month patient month patient CR mucos patient diarrhea rash patient fever patient document infect patient patient pancytopenia thrombocytopenia day initi treatment mitoxantron high-dos effect antileukem regimen high incid mucos strategi mucos damag toler combin